Fund Holdings — Exome Asset Management LLC

Total Portfolio Value:
$132.91M
Total Bought:
$55.11M
Total Sold:
$72.48M
Net Transaction:
-$17.37M
Notable People:
Alex R Forschner
Securities
▲▼
SharesValue
Q3 2024
▲▼
Q4 2024
▲▼
Change
▲▼
Q3 2024
▲▼
Q4 2024
▲▼
Weight (%)
▲▼
Change
▲▼
BridgeBio Pharma, Inc.(BBIO)211,000246,700+35,700$5.37M$6.77M5.09%+$1.40M
Eli Lilly and Company(LLY)10,4478,247-2,200$9.26M$6.37M4.79%-$2.89M
Geron Corporation(GERN)905,1261,561,152+656,026$4.11M$5.62M4.23%+$1.51M
Humana Inc.(HUM)018,066+18,066$0$4.58M3.45%+$4.58M
Guardant Health, Inc.(GH)89,800147,800+58,000$2.06M$4.52M3.40%+$2.46M
Relay Therapeutics, Inc.(RLAY)414,6291,083,487+668,858$2.94M$4.46M3.36%+$1.53M
Disc Medicine, Inc.(IRON)64,51669,072+4,556$3.17M$4.38M3.29%+$1.21M
Syndax Pharmaceuticals, Inc.(SNDX)0318,900+318,900$0$4.22M3.17%+$4.22M
Arvinas, Inc.(ARVN)0218,700+218,700$0$4.19M3.15%+$4.19M
Structure Therapeutics IncADS120,165151,965+31,800$5.27M$4.12M3.10%-$1.15M
Intuitive Surgical, Inc.(ISRG)7,4277,4270$3.65M$3.88M2.92%+$227.9K
Apellis Pharmaceuticals Inc
COM
100,367119,467+19,100$2.89M$3.81M2.87%+$917.6K
Bristol-Myers Squibb Company(BMY)78,00065,200-12,800$4.04M$3.69M2.77%-$348.0K
Boston Scientific Corporation(BSX)040,500+40,500$0$3.62M2.72%+$3.62M
Natera, Inc.(NTRA)22,45022,4500$2.85M$3.55M2.67%+$703.8K
Soleno Therapeutics Inc077,285+77,285$0$3.47M2.61%+$3.47M
Scholar Rock Holding Corporation(SRRK)133,03977,439-55,600$1.12M$3.35M2.52%+$2.23M
Nuvalent Inc19,94540,580+20,635$2.04M$3.19M2.40%+$1.15M
Cytokinetics, Incorporated(CYTK)58,58365,883+7,300$3.09M$3.10M2.33%+$6.0K
Blueprint Medicines Corp36,70031,800-4,900$3.39M$2.77M2.09%-$621.2K
Gilead Sciences, Inc.(GILD)50,00029,700-20,300$4.19M$2.74M2.06%-$1.45M
Summit Therapeutics Inc.(SMMT)0130,412+130,412$0$2.33M1.75%+$2.33M
Centessa Pharmaceuticals PlcADS138,152137,716-436$2.21M$2.31M1.74%+$97.7K
Edgewise Therapeutics, Inc.(EWTX)59,90081,473+21,573$1.60M$2.18M1.64%+$576.6K
Janux Therapeutics, Inc.(JANX)040,123+40,123$0$2.15M1.62%+$2.15M
Savara Inc.(SVRA)0699,698+699,698$0$2.15M1.62%+$2.15M
Ionis Pharmaceuticals, Inc.(IONS)061,367+61,367$0$2.15M1.61%+$2.15M
Penumbra, Inc.(PEN)09,000+9,000$0$2.14M1.61%+$2.14M
Rocket Pharmaceuticals, Inc.(RCKT)0159,552+159,552$0$2.01M1.51%+$2.01M
Akero Therapeutics Inc77,10068,608-8,492$2.21M$1.91M1.44%-$303.3K
Dr. Reddy's Laboratories LimitedADR(RDY)36,300117,500+81,200$2.88M$1.86M1.40%-$1.03M
BeOne Medicines AGADR(ONC)15,30010,000-5,300$3.44M$1.85M1.39%-$1.59M
89bio Inc300,600225,323-75,277$2.22M$1.76M1.33%-$462.4K
Tarsus Pharmaceuticals, Inc.(TARS)45,60028,178-17,422$1.50M$1.56M1.17%+$60.4K
Karyopharm Therapeutics IncNOTE 3 000 10 12,000,0002,000,0000$1.52M$1.56M1.17%+$36.4K
Pliant Therapeutics, Inc.(PLRX)149,600103,504-46,096$1.68M$1.36M1.03%-$313.9K
Fulcrum Therapeutics, Inc.(FULC)0283,599+283,599$0$1.33M1.00%+$1.33M
Stoke Therapeutics, Inc.(STOK)176,600113,096-63,504$2.17M$1.25M0.94%-$923.0K
Legend Biotech CorporationADS(LEGN)47,00037,600-9,400$2.29M$1.22M0.92%-$1.07M
Tectonic Therapeutic, Inc.(TECX)36,34426,081-10,263$1.10M$1.20M0.91%+$102.9K
Alvotech(ALVO)90,10090,1000$1.07M$1.19M0.90%+$119.8K
Yarrow Bioscience Inc(YARW)353,434353,4340$664.5K$1.18M0.89%+$519.5K
Eledon Pharmaceuticals, Inc.(ELDN)0256,373+256,373$0$1.06M0.79%+$1.06M
Biohaven Ltd.(BHVN)028,159+28,159$0$1.05M0.79%+$1.05M
Gossamer Bio, Inc.(GOSS)468,4991,097,999+629,500$462.1K$993.3K0.75%+$531.1K
Aclaris Therapeutics, Inc.(ACRS)0389,333+389,333$0$965.5K0.73%+$965.5K
Annexon, Inc.(ANNX)0144,830+144,830$0$743.0K0.56%+$743.0K
Veru Inc.(VERU)01,117,600+1,117,600$0$739.5K0.56%+$739.5K
Acelyrin Inc0234,435+234,435$0$736.1K0.55%+$736.1K
Replimune Group, Inc.(REPL)054,738+54,738$0$662.9K0.50%+$662.9K
Establishment Labs Holdings Inc.(ESTA)21,70013,100-8,600$939.0K$603.5K0.45%-$335.4K
Nektar Therapeutics(NKTR)0618,174+618,174$0$574.9K0.43%+$574.9K
Aprea Therapeutics, Inc.(APRE)137,174127,960-9,214$377.2K$419.7K0.32%+$42.5K
Akebia Therapeutics, Inc.(AKBA)0205,956+205,956$0$391.3K0.29%+$391.3K
Madrigal Pharmaceuticals, Inc.(MDGL)0987+987$0$304.6K0.23%+$304.6K
Cypherpunk Technologies Inc.(CYPH)102,631102,6310$263.8K$295.1K0.22%+$31.3K
Mersana Therapeutics Inc1,178,570172,924-1,005,646$2.23M$249.7K0.19%-$1.98M
Arbutus Biopharma Corporation(ABUS)028,300+28,300$0$92.5K0.07%+$92.5K
Acrivon Therapeutics Inc116,7570-116,757$817.3K$0—-$817.3K
Adagene IncADS262,6250-262,625$583.0K$0—-$583.0K
Agios Pharmaceuticals, Inc.(AGIO)66,2000-66,200$2.94M$0—-$2.94M
Align Technology Inc18,7000-18,700$4.76M$0—-$4.76M
Amgen Inc.(AMGN)6,7000-6,700$2.16M$0—-$2.16M
Ascendis Pharma A/SADR(ASND)43,8490-43,849$6.55M$0—-$6.55M
BioCryst Pharmaceuticals, Inc.(BCRX)196,5000-196,500$1.49M$0—-$1.49M
Biogen Inc.(BIIB)13,3170-13,317$2.57M$0—-$2.57M
BioNTech SEADS(BNTX)34,5520-34,552$4.10M$0—-$4.10M
Glaukos Corporation(GKOS)25,8570-25,857$3.37M$0—-$3.37M
Insmed Incorporated(INSM)33,6000-33,600$2.45M$0—-$2.45M
Kura Oncology, Inc.(KURA)90,3050-90,305$1.76M$0—-$1.76M
Lexeo Therapeutics, Inc.(LXEO)88,1480-88,148$796.9K$0—-$796.9K
Pacific Biosciences of California, Inc.(PACB)75,3000-75,300$128.0K$0—-$128.0K
Procaps Group SaSHS126,9010-126,901$280.5K$0—-$280.5K
Quanterix Corporation(QTRX)73,5010-73,501$952.6K$0—-$952.6K
Revance Therapeutics Inc347,6000-347,600$1.80M$0—-$1.80M
Rezolute, Inc.(RZLT)352,0560-352,056$1.71M$0—-$1.71M
Springworks Therapeutics Inc100,7000-100,700$3.23M$0—-$3.23M
STAAR Surgical Company(STAA)40,8000-40,800$1.52M$0—-$1.52M
Syros Pharmaceuticals Inc298,5750-298,575$641.9K$0—-$641.9K
TG Therapeutics, Inc.(TGTX)207,6270-207,627$4.86M$0—-$4.86M
The Cigna Group(CI)12,2000-12,200$4.23M$0—-$4.23M
Viridian Therapeutics, Inc.(VRDN)174,4000-174,400$3.97M$0—-$3.97M
Page 1 of 1
Exome Asset Management LLC — 13F Holdings — Q4 2024 | TickerTrail